Furosemide (F) pharmacodynamics in VLBW infants have not been described following initial and subsequent doses during chronic adminstration. F acts from the luminal side of the loop of Henle and there ...

Findings from an open-label study evaluating the effect of sacubitril/valsartan on the pharmacokinetics (PK) and pharmacodynamics (PD) of furosemide showed no significant impact among healthy patients ...

The FDA approved the first furosemide (Furoscix) formulation for subcutaneous self-administration by patients with congestive heart failure, scPharmaceuticals announced. The IV-equivalent formulation ...

Selected patients with heart failure who are doing well on optimal guideline-directed medical therapy, including furosemide, may be safely taken off loop diuretics without raising their risk for ...

It remains unclear why our patient did not develop the electrolyte abnormalities typical for furosemide-induced hypokalemia. Her concomitant hyponatremia cannot be explained by furosemide-intake since ...